ArticleACS sensors2025
High-Selectivity Nonenzymatic Creatinine Sensor Using Electrografted Ionic Liquid and Nafion for Reliable Clinical Diagnostics.
Article in ACS sensors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid and accurate detection of creatinine is essential for monitoring kidney function and diagnosing renal impairments. Nonenzymatic catalysts have been used to improve sensitivity and reduce environmental susceptibility in creatinine detection. However, limited selectivity hinders their broader application in practical scenarios. This study introduced a novel nonenzymatic creatinine sensor that utilized copper(II) oxide as a catalyst, incorporating styrenyl-triphenylphosphonium-based ionic liquid (STPP-IL) and Nafion on the electrode surface to enhance selectivity and minimize interference. Electrografting technique ensured uniform STPP-IL coverage on the electrode, as confirmed by scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDS). The modified creatinine sensors demonstrated a detection range from 1.5 to 800 μM with low standard error and high sensitivities in the presence of interferents. Notably, creatinine levels in the artificial and natural human sweat were selectively quantified using the proposed sensor, supporting its potential for clinical applications. The sensors retained over 90% of their initial current response after 40 days of storage. Additionally, reproducibility experiments demonstrated a relative error of 1.3% across five independent sensors. These results show the sensor's enhanced selectivity, stability, and reproducibility, making it a promising alternative for reliable creatinine detection in point-of-care tests.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.